← Back to Clinical Trials
Recruiting NCT06723301

NCT06723301 Chatbot-based Assistant to Improve Problem-solving Skills in Parents of Children With ASD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06723301
Status Recruiting
Phase
Sponsor Hong Kong Metropolitan University
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2024-12-12
Primary Completion 2025-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Chatbot-base problem-solving skills training(PSST)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2024-12-12 with a primary completion date of 2025-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to evaluate how a Chatbot-based assistant can improve problem-solving skills and coping strategies in parents of children with Autism Spectrum Disorder (ASD).

Eligibility Criteria

The inclusion criteria are parents: (i) providing long-term care for children with a diagnosis of ASD from a qualified clinician according to the Diagnostic and Statistics Manual of Mental Disorders - Fifth Edition (DSM-5), confirmed through the provision of written documentation by parents, (ii) who identified as the primary caregiver of the children with ASD, (iii) who are older than 18 years old, and (iv) who have the ability to communicate in and read Chinese. Exclusion Criteria are parents: (i) who attended other parent training programs at the same time, (ii) who declined to complete the three scheduled assessments, and (iii) who had a diagnosis of severe psychiatric disorders (such as schizophrenia and severe bipolar disorder) or cognitive impairment.

Contact & Investigator

Central Contact

Wendy Zhang

✉ wwzhang@hkmu.edu.hk

📞 39702945

Frequently Asked Questions

Who can join the NCT06723301 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06723301 currently recruiting?

Yes, NCT06723301 is actively recruiting participants. Contact the research team at wwzhang@hkmu.edu.hk for enrollment information.

Where is the NCT06723301 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06723301 clinical trial?

NCT06723301 is sponsored by Hong Kong Metropolitan University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology